United States: FDA Issues First Untitled Letter Of The Year To Xeris Pharmaceuticals - Sheppard Mullin Richter & Hampton

The wait is finally over. On June 7, 2023, after remaining silent for over an entire year, the US Food and Drug Administration ("FDA") Office of Prescription Drug Promotion ("OPDP") issued its first untitled...